Synergistic cytotoxic effects of BromAc® on non-small cell lung cancer cell lines. - Amsterdam 2025

Translating in the omics milky way of lung cancer

Chair(s): Merel Hellemons, Torsten Gerriet Blum

Session type: Oral presentation

Synergistic cytotoxic effects of BromAc® on non-small cell lung cancer cell lines.

David L. Morris

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - High level of Prevotella melanogenic in the lower respiratory microbiota of Checkpoint inhibitor pneumonitis and radiation pneumonitis

Xueling Wu

Replay

Abstract

Slides

Establishment of a mouse model to investigate the therapeutic potential of focal adhesion kinase inhibition in small cell lung cancer

Céline Decouvreur

Replay

Poster

Abstract

Slides

Identification of the phosphoproteome downstream of focal adhesion kinase inhibition in small cell lung cancer

Céline Decouvreur

Replay

Poster

Abstract

Slides

A Novel Flavonoid Derivative JW6 Suppresses Non-small Cell Lung Cancer Progression Via Activating Mitochondrial Apoptosis And Inhibiting PI3K/Akt/mTOR Pathway

Yuting Lin

Replay

Poster

Abstract

Slides

Immunomodulatory properties of cancer-associated fibroblasts in non-small cell lung cancer: studies in a 3D lung tumor model

Janne Drews

Poster

Abstract

Slides

Exploring the impact of the fibrotic microenvironment on lung tumors using a 3D multicellular spheroid model

Marina Tuxans Serrano

Replay

Poster

Abstract

Slides

Talaporfin-Mediated Photodynamic Therapy Enhances Antitumor Immunity via the ROS/HIF-1?/PD-L1 Pathway in Non-Small Cell Lung Cancer

Zhou Jin

Replay

Poster

Abstract

Slides

Synergistic cytotoxic effects of BromAc® on non-small cell lung cancer cell lines.

David L. Morris

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}